-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
June 11, 2019 - be-
tween PrEP vs placebo in pregnancy rate, risk of preterm birth, birth
anomalies, or postpartum infant … mortality, and the FEM-PrEP trial
Figure 4.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
March 08, 2004 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary
Hepatitis C Virus Infection: Screening, 2004
March 08, 2004
Recommendations made by the USPSTF are independent of the U.S. government. They should…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aJ-xmGLsKqLQbQsBqodKZ5
January 01, 2001 - PII: S0749-3797(01)00266-5
Screening Adults for Lipid Disorders
Recommendations and Rationale
U.S. Preventive Services Task Force
Summary of Recommendations
● The U.S. Preventive Services Task Force (USPSTF)
strongly recommends that clinicians routinely screen
men aged 35 years and older and women aged 45
years and…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
March 14, 2014 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001
March 14, 2014
Recommendations made by the USPSTF are ind…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
January 01, 2018 - Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services
High-Priority
Evidence Gaps for
Clinical Preventive
Services
EIGHTH ANNUAL
REPORT TO CONGRESS
NOVEMBER 2018
SUBMITTED BY:
Dr. Susan J. Curry, Chair
Dr. Alex H. Krist, Vice Chair
Dr. Douglas K. Owens, Vice Cha…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
June 11, 2019 - differences between PrEP vs placebo in pregnancy rate, risk of preterm birth, birth anomalies, or postpartum infant … mortality, and the FEM-PrEP trial (n = 2120) found no significant difference in risk of any adverse
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - differences between PrEP vs placebo in pregnancy rate, risk of preterm birth, birth anomalies, or postpartum infant … mortality, and the FEM-PrEP trial (n = 2120) found no significant difference in risk of any adverse
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/elevated-lead-levels-childhood-pregnancy-screening-1996
January 01, 1996 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Elevated Lead Levels in Childhood and Pregnancy: Screening, 1996
January 01, 1996
Recommendations made by the USPSTF are independe…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
May 02, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Latent Tuberculosis Infection in Adults: Screening
May 02, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They should not …
-
www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening
May 15, 2013 - Screening: Evidence Summary
Gestational Diabetes Mellitus, Screening
May 15, 2013
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Servi…
-
www.uspreventiveservicestaskforce.org/uspstf/document/-screening-evidence-summary/gestational-diabetes-mellitus-screening-january-2014
May 15, 2013 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Screening: Evidence Summary
Gestational Diabetes Mellitus, Screening
May 15, 2013
Recommendations made by the USPSTF are independent of the U.S. government. They…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force
Hepatitis C virus (HCV), the most common
chronic blood-borne pathogen in the United
States, is acquired primarily by large or repeated
percutaneous exposures to blood.1 In the United
States, appro…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/38JVCyPEw7CNrmZN6twpM6
July 01, 2021 - Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement
Clinical Review & Education
(Reprinted)
JAMA | US Preventive Services Task Force | RECOMMENDATION STATEMENT
Screening for Chlamydia and Gonorrhea
US Preventive Services Task Force Recommendation Statement
US Preve…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2013%20(4).pdf
November 01, 2013 - High-Priority Evidence Gaps for Clinical Preventive Services
HIGH-PRIORITY EVIDENCE GAPS
FOR CLINICAL PREVENTIVE SERVICES
:
THIRD ANNUAL REPORT TO CONGRESS
NOVEMBER 2013
SUBMITTED BY
Dr. Virginia Moyer, Chair
Dr. Michael LeFevre, Vice Chair
Dr. Albert Siu, Vice Chair
ON BEHALF OF THE U.S. PREVENTIVE
SER…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening
August 09, 2016 - Share to Facebook
Share to Twitter
Share to WhatsApp
Share to E-mail
Print
Evidence Summary: Screening for Familial Hypercholesterolemia
Lipid Disorders in Children and Adolescents: Screening
August 09, 2016
Recomme…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening-july-2016
August 09, 2016 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Evidence Summary: Screening for Familial Hypercholesterolemia
Lipid Disorders in Children and Adolescents: Screening
August 09, 2016
Recommendations made by the USP…
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
November 13, 2018 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions
November 13, 2018
Recommendations made by the USPSTF are inde…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2003
February 04, 2003 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Diabetes Mellitus (Type 2) in Adults: Screening, 2003
February 04, 2003
Recommendations made by the USPSTF are independent of the U…
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/update-methods-insufficient-evidence
March 04, 2021 - Update on Methods: Insufficient Evidence
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Table of Contents Preface Abstract Introduction Problem Statement Acknowledging the Contribution of Non-RCT Evidence and Persisting I…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
August 22, 2023 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Evidence Summary
Prevention of Acquisition of HIV: Preexposure Prophylaxis
August 22, 2023
Recommendations made by the USPSTF are independent of the U.S. government. They shou…